We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
CLU is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
2811.6
Number of samples
349
Samples
Sample
Description
TPM
TCGA-29-1693-01A
0 years, female, white, stage:Stage IIIC, alive, 3096 days
19184.2
TCGA-24-1616-01A
0 years, female, white, stage:Stage IIIC, dead, 1163 days
18529.3
TCGA-57-1584-01A
0 years, female, white, stage:Stage IIIC, alive, 643 days
16225.9
TCGA-20-1687-01A
0 years, female, white, stage:Stage IV, alive, 81 days
15205.8
TCGA-29-1703-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
15133.0
TCGA-13-0720-01A
0 years, female, white, stage:Stage IIIC, dead, 1355 days
14846.3
TCGA-13-1498-01A
0 years, female, white, stage:Stage IIIC, dead, 2012 days
14838.9
TCGA-29-1763-01A
0 years, female, black or african american, stage:Stage IIC, alive, 2032 days
14525.1
TCGA-13-0923-01A
0 years, female, white, stage:Stage IIIC, alive, 2547 days
14390.4
TCGA-24-1560-01A
0 years, female, white, stage:Stage IIIC, dead, 1341 days
13618.4
TCGA-09-2045-01A
0 years, female, asian, stage:Stage IV, dead, 1069 days
12394.2
TCGA-36-1569-01A
0 years, female, white, stage:Stage IIIC, alive, 885 days
11759.6
TCGA-04-1648-01A
0 years, female, white, stage:Stage IIIC, dead, 871 days
11416.4
TCGA-23-1023-01A
0 years, female, white, stage:Stage IIIC, alive, 1233 days
11389.3
TCGA-24-2271-01A
0 years, female, asian, stage:Stage IIIC, dead, 962 days
10129.2
TCGA-04-1519-01A
0 years, female, stage:Stage IIIC, alive, 24 days
10008.2
TCGA-13-0797-01A
0 years, female, white, stage:Stage IIIC, alive, 2121 days
9527.9
TCGA-36-1571-01A
0 years, female, white, stage:Stage IIIB, dead, 695 days
9276.7
TCGA-29-1776-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 360 days
8511.7
TCGA-24-1546-01A
0 years, female, white, stage:Stage IIIC, dead, 1955 days
8238.6
TCGA-29-1690-01A
0 years, female, white, stage:Stage IIIC, dead, 1448 days
8015.4
TCGA-61-1724-01A
0 years, female, white, stage:Stage IIIC, dead, 637 days
8008.2
TCGA-29-1694-01A
0 years, female, white, stage:Stage IIIC, dead, 1187 days
7416.6
TCGA-13-0765-01A
0 years, female, white, stage:Stage IIIC, dead, 1389 days
7359.9
TCGA-24-1562-01A
0 years, female, white, stage:Stage IIIC, dead, 1384 days
7219.1
TCGA-20-1683-01A
0 years, female, white, stage:Stage IIIC, alive, 772 days
7114.4
TCGA-24-1423-01A
0 years, female, white, stage:Stage IIIC, alive, 190 days
7054.8
TCGA-09-0367-01A
0 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
6887.5
TCGA-25-1870-01A
0 years, female, white, stage:Stage IIIC, dead, 455 days
6801.4
TCGA-24-2038-01A
0 years, female, white, stage:Stage IIIA, dead, 1354 days
6798.0
TCGA-24-1603-01A
0 years, female, white, stage:Stage IIIB, dead, 2742 days
6487.0
TCGA-61-1738-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
6334.6
TCGA-10-0927-01A
0 years, female, stage:Stage IIIC, dead, 2490 days
6185.3
TCGA-25-1328-01A
0 years, female, white, stage:Stage IIIC, dead, 2009 days
6183.2
TCGA-25-1321-01A
0 years, female, white, stage:Stage IIIC, dead, 1033 days
6147.7
TCGA-13-0726-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
6144.4
TCGA-36-1568-01A
0 years, female, stage:Stage IIIC, alive, 875 days
6085.5
TCGA-04-1542-01A
0 years, female, white, stage:Stage IIIB, dead, 2561 days
6053.0
TCGA-59-2354-01A
0 years, female, white, stage:Stage IIIC, dead, 1046 days
5987.8
TCGA-29-1688-01A
0 years, female, white, stage:Stage IIIC, dead, 2400 days
5820.5
TCGA-13-0804-01A
0 years, female, white, stage:Stage IIIC, dead, 1073 days
5661.6
TCGA-23-1027-01A
0 years, female, white, stage:Stage IIIC, dead, 976 days
5635.5
TCGA-20-0987-01A
0 years, female, white, stage:Stage IIIC, dead, 701 days
5592.1
TCGA-09-1666-01A
0 years, female, white, stage:Stage IIIC, alive, 1752 days
5545.4
TCGA-24-1103-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
5479.3
TCGA-61-1995-01A
0 years, female, white, stage:Stage IIIC, alive, 61 days
5443.5
TCGA-24-1844-01A
0 years, female, white, stage:Stage IIIC, alive, 113 days
5390.9
TCGA-24-1565-01A
0 years, female, white, stage:Stage IIIC, dead, 312 days
5308.3
TCGA-13-1485-01A
0 years, female, white, stage:Stage IV, dead, 629 days
5308.1
TCGA-29-1710-01A
0 years, female, white, stage:Stage IIIC, dead, 951 days
5297.2
TCGA-36-1570-01A
0 years, female, white, stage:Stage IIIC, alive, 655 days
5238.8
TCGA-13-0891-01A
0 years, female, white, stage:Stage IV, dead, 3128 days
5135.2
TCGA-25-1627-01A
0 years, female, white, stage:Stage IIIC, dead, 394 days
5132.8
TCGA-13-1409-01A
0 years, female, white, stage:Stage IIIC, dead, 1742 days
5076.4
TCGA-59-2348-01A
0 years, female, white, stage:Stage IIIC, alive, 5481 days
5025.9
TCGA-25-1313-01A
0 years, female, white, stage:Stage IV, dead, 820 days
4896.9
TCGA-OY-A56Q-01A
0 years, female, black or african american, stage:Stage IIA, alive, 576 days
4877.7
TCGA-61-2003-01A
0 years, female, white, stage:Stage IIIC, alive, 122 days
4816.9
TCGA-24-1430-01A
0 years, female, white, stage:Stage IIIC, dead, 863 days
4801.8
TCGA-09-1670-01A
0 years, female, white, stage:Stage IIIA, alive, 547 days
4800.7
TCGA-04-1343-01A
0 years, female, white, stage:Stage IV, dead, 361 days
4792.6
TCGA-29-1697-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
4777.3
TCGA-25-1632-01A
0 years, female, white, stage:Stage IV, dead, 1799 days
4597.4
TCGA-13-1405-01A
0 years, female, white, stage:Stage IV, dead, 868 days
4585.7
TCGA-24-1422-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 23 days
4575.2
TCGA-31-1959-01A
0 years, female, white, stage:Stage IV, alive, 67 days
4403.0
TCGA-30-1862-01A
0 years, female, white, stage:Stage IV, dead, 186 days
4307.3
TCGA-24-2298-01A
0 years, female, white, stage:Stage IIIC, dead, 1620 days
4289.1
TCGA-23-1118-01A
0 years, female, white, stage:Stage IIIC, alive, 2616 days
4285.4
TCGA-13-1511-01A
0 years, female, asian, stage:Stage IV, dead, 1650 days
4276.1
TCGA-61-2012-01A
0 years, female, white, stage:Stage IIC, alive, 932 days
4221.6
TCGA-13-0800-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
4170.9
TCGA-25-1631-01A
0 years, female, white, stage:Stage IIIC, dead, 9 days
4151.1
TCGA-36-1580-01A
0 years, female, stage:Stage IIIC, dead, 737 days
4113.8
TCGA-24-2026-01A
0 years, female, white, stage:Stage IIIC, dead, 1059 days
4106.0
TCGA-25-2392-01A
0 years, female, white, stage:Stage IV, dead, 31 days
4084.3
TCGA-24-1552-01A
0 years, female, white, stage:Stage IIIC, dead, 1259 days
4064.5
TCGA-13-0887-01A
0 years, female, white, stage:Stage IIIC, dead, 2028 days
4017.3
TCGA-59-2355-01A
0 years, female, white, stage:Stage IV, dead, 65 days
3991.6
TCGA-23-1111-01A
0 years, female, white, stage:Stage IIIC, alive, 98 days
3958.0
TCGA-24-1563-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
3957.3
TCGA-VG-A8LO-01A
0 years, female, black or african american, stage:Stage IV, dead, 24 days
3931.9
TCGA-10-0937-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
3900.8
TCGA-30-1892-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
3886.7
TCGA-57-1583-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 346 days
3852.7
TCGA-13-A5FT-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
3822.4
TCGA-24-2023-01A
0 years, female, white, stage:Stage IIIA, dead, 1364 days
3721.2
TCGA-13-1410-01A
0 years, female, white, stage:Stage IV, alive, 2464 days
3677.5
TCGA-25-2409-01A
0 years, female, white, stage:Stage IV, dead, 821 days
3653.8
TCGA-09-2051-01A
0 years, female, white, stage:Stage IIIC, alive, 1919 days
3615.9
TCGA-25-2399-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
3509.0
TCGA-13-1497-01A
0 years, female, white, stage:Stage IIIC, alive, 3871 days
3507.6
TCGA-24-2036-01A
0 years, female, white, stage:Stage IIIA, dead, 1947 days
3502.2
TCGA-29-1766-01A
0 years, female, white, stage:Stage IIIC, dead, 1199 days
3498.6
TCGA-24-2024-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
3476.0
TCGA-61-1910-01A
0 years, female, white, stage:Stage IIC, alive, 1127 days
3474.7
TCGA-25-1329-01A
0 years, female, white, stage:Stage IIIC, dead, 457 days
3456.8
TCGA-29-2427-01A
0 years, female, white, stage:Stage IIIC, alive, 1900 days
3454.3
TCGA-29-1696-01A
0 years, female, white, stage:Stage IIIC, dead, 1032 days
3441.5
TCGA-13-0724-01A
0 years, female, white, stage:Stage IV, dead, 83 days
3426.9
TCGA-59-2350-01A
0 years, female, stage:Stage IV, dead, 679 days
3324.9
TCGA-25-2398-01A
0 years, female, white, stage:Stage IIIC, dead, 1369 days
3321.4
TCGA-24-2267-01A
0 years, female, white, stage:Stage IIB, dead, 1446 days
3242.4
TCGA-29-1711-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
3198.6
TCGA-29-2414-01A
0 years, female, white, stage:Stage IIIC, dead, 2621 days
3164.4
TCGA-57-1994-01A
0 years, female, white, stage:'--, alive, 761 days
3161.5
TCGA-24-1557-01A
0 years, female, white, stage:Stage IIIC, dead, 1213 days
3147.6
TCGA-13-0886-01A
0 years, female, white, stage:Stage IIIC, alive, 4665 days
3058.2
TCGA-23-1107-01A
0 years, female, white, stage:Stage IV, dead, 9 days
3055.5
TCGA-61-2101-01A
0 years, female, white, stage:Stage IIIC, dead, 1688 days
2974.9
TCGA-04-1331-01A
0 years, female, white, stage:Stage IIIC, dead, 1336 days
2967.1
TCGA-24-1471-01A
0 years, female, white, stage:Stage IIIC, alive, 36 days
2961.8
TCGA-31-1953-01A
0 years, female, asian, stage:Stage IIIC, alive, 204 days
2958.8
TCGA-24-1418-01A
0 years, female, white, stage:Stage IIIC, alive, 243 days
2943.9
TCGA-24-0966-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 232 days
2940.7
TCGA-24-1604-01A
0 years, female, white, stage:Stage IIIC, dead, 2688 days
2920.1
TCGA-10-0931-01A
0 years, female, white, stage:Stage IIIC, dead, 1000 days
2905.0
TCGA-29-1778-01A
0 years, female, white, stage:Stage IIIC, alive, 454 days
2902.9
TCGA-13-1403-01A
0 years, female, white, stage:Stage IIIC, dead, 2345 days
2874.4
TCGA-24-1104-01A
0 years, female, white, stage:Stage IV, dead, 1933 days
2856.5
TCGA-61-1918-01A
0 years, female, white, stage:Stage IV, dead, 479 days
2854.4
TCGA-29-1785-01A
0 years, female, white, stage:Stage IIIC, dead, 1104 days
2850.7
TCGA-04-1361-01A
0 years, female, white, stage:Stage IIIB, alive, 989 days
2843.8
TCGA-24-0979-01A
0 years, female, white, stage:Stage IV, dead, 1264 days
2789.5
TCGA-57-1586-01A
0 years, female, white, stage:Stage IIIC, alive, 679 days
2769.3
TCGA-24-1558-01A
0 years, female, white, stage:Stage IIIC, dead, 594 days
2698.0
TCGA-09-1662-01A
0 years, female, white, stage:Stage IV, dead, 2717 days
2684.4
TCGA-25-1318-01A
0 years, female, white, stage:Stage IIIC, dead, 1064 days
2682.6
TCGA-5X-AA5U-01A
0 years, female, black or african american, stage:Stage IIC, alive, 361 days
2678.7
TCGA-61-1728-01A
0 years, female, white, stage:Stage IV, alive, 848 days
2669.7
TCGA-25-1312-01A
0 years, female, white, stage:Stage IV, dead, 31 days
2651.8
TCGA-24-1419-01A
0 years, female, white, stage:Stage IIIC, alive, 239 days
2552.4
TCGA-29-2425-01A
0 years, female, white, stage:Stage IIIC, alive, 1977 days
2517.2
TCGA-61-1733-01A
0 years, female, white, stage:Stage IIIC, alive, 967 days
2481.3
TCGA-24-1845-01A
0 years, female, white, stage:Stage IIIC, alive, 116 days
2453.7
TCGA-09-1673-01A
0 years, female, white, stage:Stage IV, alive, 92 days
2445.3
TCGA-13-0916-01A
0 years, female, white, stage:Stage IIIC, alive, 1785 days
2439.8
TCGA-13-0725-01A
0 years, female, white, stage:Stage IIIC, dead, 377 days
2430.9
TCGA-24-1553-01A
0 years, female, white, stage:Stage IIIB, dead, 1767 days
2429.3
TCGA-24-1416-01A
0 years, female, white, stage:Stage IV, alive, 194 days
2409.0
TCGA-30-1853-01A
0 years, female, white, stage:Stage IIIC, dead, 1103 days
2391.2
TCGA-24-2297-01A
0 years, female, white, stage:Stage IIIC, dead, 1699 days
2293.9
TCGA-04-1651-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
2238.0
TCGA-13-0795-01A
0 years, female, white, stage:Stage IIIC, dead, 619 days
2235.0
TCGA-24-1425-01A
0 years, female, white, stage:Stage IIIC, alive, 181 days
2219.7
TCGA-13-1495-01A
0 years, female, white, stage:Stage IIIC, dead, 2749 days
2211.5
TCGA-30-1866-01A
0 years, female, white, stage:Stage IV, dead, 1114 days
2203.1
TCGA-24-2290-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
2200.3
TCGA-25-2042-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
2185.7
TCGA-24-1544-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 820 days
2183.5
TCGA-59-2352-01A
0 years, female, white, stage:Stage IIIC, dead, 286 days
2170.2
TCGA-13-1512-01A
0 years, female, white, stage:Stage IIIC, alive, 442 days
2163.0
TCGA-61-2104-01A
0 years, female, white, stage:Stage IIC, alive, 2338 days
2141.9
TCGA-23-1028-01A
0 years, female, white, stage:Stage IIIC, alive, 1503 days
2138.9
TCGA-13-0727-01A
0 years, female, white, stage:Stage IIIC, dead, 462 days
2107.2
TCGA-23-1119-01A
0 years, female, white, stage:Stage IIIC, alive, 3953 days
2081.3
TCGA-36-1574-01A
0 years, female, asian, stage:Stage IIIC, alive, 686 days
2075.4
TCGA-24-1426-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
2067.8
TCGA-31-1951-01A
0 years, female, white, stage:Stage IIIC, alive, 684 days
2024.1
TCGA-04-1341-01A
0 years, female, white, stage:'--, alive, 33 days
2022.0
TCGA-25-1316-01A
0 years, female, white, stage:Stage IIIC, dead, 1279 days
1989.5
TCGA-61-2088-01A
0 years, female, white, stage:Stage IIIC, alive, 145 days
1978.5
TCGA-24-2288-01A
0 years, female, white, stage:Stage IIIC, dead, 25 days
1945.2
TCGA-61-2008-01A
0 years, female, asian, stage:Stage IIC, alive, 932 days
1928.4
TCGA-29-A5NZ-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
1901.6
TCGA-04-1655-01A
0 years, female, white, stage:Stage IIIB, dead, 1380 days
1898.4
TCGA-23-1122-01A
0 years, female, white, stage:Stage IIIC, dead, 1189 days
1898.0
TCGA-13-1488-01A
0 years, female, white, stage:Stage IV, dead, 2154 days
1865.2
TCGA-30-1857-01A
0 years, female, white, stage:Stage IV, dead, 8 days
1850.2
TCGA-29-1783-01A
0 years, female, white, stage:Stage IIIC, alive, 220 days
1842.1
TCGA-24-1417-01A
0 years, female, white, stage:Stage IV, alive, 238 days
1841.2
TCGA-24-1924-01A
0 years, female, white, stage:Stage IIIC, dead, 919 days
1835.3
TCGA-24-1549-01A
0 years, female, white, stage:Stage IIIB, dead, 1721 days
1835.1
TCGA-25-2396-01A
0 years, female, white, stage:Stage IIIC, dead, 92 days
1827.9
TCGA-30-1718-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
1824.6
TCGA-25-1320-01A
0 years, female, white, stage:Stage IIIC, dead, 1155 days
1812.8
TCGA-25-1319-01A
0 years, female, white, stage:Stage IIIC, dead, 1977 days
1782.3
TCGA-24-1434-01A
0 years, female, white, stage:Stage IIIC, dead, 568 days
1770.9
TCGA-20-1682-01A
0 years, female, white, stage:Stage IIIC, alive, 837 days
1768.1
TCGA-59-2351-01A
0 years, female, white, stage:Stage IIIC, alive, 3532 days
1742.0
TCGA-25-1628-01A
0 years, female, white, stage:Stage IIIC, dead, 627 days
1726.1
TCGA-29-1770-01A
0 years, female, white, stage:Stage IIIC, alive, 741 days
1726.1
TCGA-24-1413-01A
0 years, female, white, stage:Stage IIIC, alive, 192 days
1688.3
TCGA-24-1923-01A
0 years, female, white, stage:Stage IIIC, dead, 690 days
1685.2
TCGA-61-2109-01A
0 years, female, white, stage:Stage IIIC, dead, 629 days
1663.9
TCGA-24-1469-01A
0 years, female, white, stage:Stage IIIC, alive, 277 days
1661.8
TCGA-04-1332-01A
0 years, female, white, stage:Stage IIIC, dead, 1247 days
1639.9
TCGA-13-0768-01A
0 years, female, white, stage:Stage IIIC, dead, 1784 days
1637.8
TCGA-13-0766-01A
0 years, female, white, stage:Stage IIIC, dead, 1725 days
1619.7
TCGA-61-1914-01A
0 years, female, stage:Stage IIIC, alive, 1722 days
1587.2
TCGA-13-1506-01A
0 years, female, white, stage:Stage IIIC, dead, 1039 days
1538.5
TCGA-57-1993-01A
0 years, female, white, stage:Stage IIIC, alive, 763 days
1516.9
TCGA-24-1847-01A
0 years, female, white, stage:Stage IV, alive, 343 days
1494.3
TCGA-57-1585-01A
0 years, female, white, stage:Stage IIIC, dead, 53 days
1491.4
TCGA-61-2009-01A
0 years, female, white, stage:Stage IIIC, alive, 1212 days
1477.7
TCGA-24-1435-01A
0 years, female, white, stage:Stage IIIC, dead, 1324 days
1436.8
TCGA-31-1950-01A
0 years, female, white, stage:Stage IIIC, alive, 571 days
1432.8
TCGA-04-1350-01A
0 years, female, white, stage:Stage IIIC, dead, 1946 days
1402.7
TCGA-23-1120-01A
0 years, female, white, stage:Stage IIIC, alive, 130 days
1400.1
TCGA-13-0897-01A
0 years, female, white, stage:Stage IIIC, dead, 2182 days
1396.2
TCGA-24-2033-01A
0 years, female, white, stage:Stage IIIC, dead, 562 days
1387.7
TCGA-24-2280-01A
0 years, female, white, stage:Stage IIIC, alive, 2143 days
1375.8
TCGA-61-2111-01A
0 years, female, white, stage:Stage IV, alive, 3825 days
1340.9
TCGA-61-2110-01A
0 years, female, white, stage:Stage IIIC, dead, 1354 days
1329.2
TCGA-24-1467-01A
0 years, female, white, stage:Stage IIIC, dead, 3224 days
1326.3
TCGA-13-1496-01A
0 years, female, white, stage:Stage IIIC, dead, 129 days
1322.8
TCGA-23-2077-01A
0 years, female, white, stage:Stage IIIC, alive, 3525 days
1317.8
TCGA-61-2097-01A
0 years, female, white, stage:Stage IIC, alive, 1844 days
1310.7
TCGA-29-1695-01A
0 years, female, white, stage:Stage IIIC, dead, 1229 days
1284.6
TCGA-13-0920-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
1276.3
TCGA-31-1946-01A
0 years, female, stage:Stage IIIC, alive, 918 days
1275.2
TCGA-25-1315-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
1262.8
TCGA-13-1510-01A
0 years, female, white, stage:Stage IIIC, dead, 1359 days
1216.9
TCGA-24-1842-01A
0 years, female, white, stage:Stage IIIC, alive, 253 days
1212.9
TCGA-23-1123-01A
0 years, female, white, stage:Stage IIIC, dead, 1018 days
1176.2
TCGA-23-1110-01A
0 years, female, white, stage:Stage IIIC, alive, 1658 days
1164.6
TCGA-04-1365-01A
0 years, female, white, stage:Stage IIIB, alive, 947 days
1158.7
TCGA-10-0928-01A
0 years, female, white, stage:Stage IIIC, dead, 563 days
1136.8
TCGA-36-1581-01A
0 years, female, white, stage:Stage IIC, alive, 751 days
1123.5
TCGA-23-1030-01A
0 years, female, white, stage:Stage IIIC, alive, 886 days
1111.7
TCGA-24-2254-01A
0 years, female, white, stage:Stage IIIC, dead, 1736 days
1106.4
TCGA-24-1846-01A
0 years, female, stage:Stage IIIC, alive, 133 days
1095.9
TCGA-30-1860-01A
0 years, female, white, stage:Stage IIIC, dead, 1366 days
1075.7
TCGA-13-0924-01A
0 years, female, white, stage:Stage IV, alive, 2614 days
1072.8
TCGA-04-1362-01A
0 years, female, white, stage:Stage IIC, dead, 1348 days
1055.4
TCGA-25-2404-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
1055.1
TCGA-13-0906-01A
0 years, female, white, stage:Stage IIIC, alive, 3619 days
1041.2
TCGA-23-1022-01A
0 years, female, white, stage:Stage IIIC, dead, 1511 days
1036.1
TCGA-13-1489-01A
0 years, female, white, stage:Stage IIIC, dead, 2553 days
1019.6
TCGA-24-1424-01A
0 years, female, white, stage:Stage IIIC, alive, 183 days
1010.0
TCGA-25-2400-01A
0 years, female, white, stage:Stage IIIC, dead, 1278 days
1009.7
TCGA-24-1928-01A
0 years, female, white, stage:Stage IIIC, dead, 336 days
1000.6
TCGA-23-2084-01A
0 years, female, white, stage:Stage IV, dead, 1516 days
992.8
TCGA-24-1431-01A
0 years, female, white, stage:Stage IIIC, dead, 583 days
988.1
TCGA-13-1507-01A
0 years, female, white, stage:Stage IIIC, dead, 1993 days
978.4
TCGA-61-2002-01A
0 years, female, white, stage:Stage IIIC, alive, 547 days
977.1
TCGA-04-1347-01A
0 years, female, white, stage:Stage IV, alive, 1919 days
959.5
TCGA-24-2020-01A
0 years, female, white, stage:Stage IIIC, dead, 4624 days
954.5
TCGA-23-1024-01A
0 years, female, white, stage:Stage IV, alive, 468 days
953.1
TCGA-13-1408-01A
0 years, female, white, stage:Stage IIIC, dead, 1680 days
943.6
TCGA-25-1317-01A
0 years, female, white, stage:Stage IIIC, dead, 61 days
927.4
TCGA-09-0369-01A
0 years, female, white, stage:Stage IIIC, dead, 1082 days
923.4
TCGA-61-1919-01A
0 years, female, white, stage:Stage IIIC, dead, 1161 days
922.6
TCGA-13-0883-01A
0 years, female, white, stage:Stage IIIC, dead, 2097 days
918.0
TCGA-24-2035-01A
0 years, female, white, stage:Stage IIIC, dead, 857 days
917.9
TCGA-04-1536-01A
0 years, female, black or african american, stage:Stage IV, dead, 885 days
911.2
TCGA-30-1714-01A
0 years, female, white, stage:Stage IV, dead, 1158 days
908.8
TCGA-13-1483-01A
0 years, female, white, stage:Stage IIIC, dead, 895 days
892.2
TCGA-23-1809-01A
0 years, female, white, stage:Stage IIC, alive, 16 days
890.7
TCGA-25-1326-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
888.5
TCGA-29-1701-01A
0 years, female, white, stage:Stage IIIC, dead, 515 days
888.3
TCGA-13-0714-01A
0 years, female, white, stage:Stage IV, dead, 189 days
886.1
TCGA-24-1105-01A
0 years, female, white, stage:Stage IIIC, dead, 1442 days
875.8
TCGA-13-0885-01A
0 years, female, white, stage:Stage IIIC, alive, 3388 days
870.7
TCGA-61-1911-01A
0 years, female, white, stage:Stage IIA, alive, 1293 days
864.5
TCGA-25-1634-01A
0 years, female, white, stage:Stage IIIC, dead, 1091 days
818.7
TCGA-29-1777-01A
0 years, female, white, stage:Stage IIIC, alive, 374 days
816.9
TCGA-20-0991-01A
0 years, female, white, stage:Stage IIB, alive, 797 days
815.2
TCGA-23-1113-01A
0 years, female, white, stage:Stage IV, dead, 949 days
811.6
TCGA-29-1784-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
809.9
TCGA-24-2281-01A
0 years, female, white, stage:Stage IIA, alive, 1357 days
806.2
TCGA-24-2293-01A
0 years, female, white, stage:'--, dead, 506 days
798.2
TCGA-23-2078-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
791.2
TCGA-24-1930-01A
0 years, female, white, stage:Stage IIIC, dead, 2467 days
790.3
TCGA-13-1501-01A
0 years, female, white, stage:Stage IV, dead, 1314 days
789.9
TCGA-13-1505-01A
0 years, female, white, stage:Stage IIIC, alive, 1998 days
785.0
TCGA-25-1635-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
773.7
TCGA-25-1322-01A
0 years, female, white, stage:Stage IV, dead, 91 days
771.9
TCGA-24-1464-01A
0 years, female, white, stage:Stage IIIC, dead, 379 days
768.2
TCGA-13-0730-01A
0 years, female, white, stage:Stage IIIC, dead, 542 days
759.2
TCGA-61-1900-01A
0 years, female, black or african american, stage:Stage IIIB, alive, 176 days
710.4
TCGA-10-0938-01A
0 years, female, white, stage:Stage IIIC, dead, 636 days
692.7
TCGA-24-2261-01A
0 years, female, white, stage:Stage IIIC, dead, 24 days
690.2
TCGA-61-1725-01A
0 years, female, white, stage:Stage IIIC, alive, 956 days
659.8
TCGA-24-1850-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
646.3
TCGA-29-1705-01A
0 years, female, white, stage:Stage IIIC, dead, 555 days
644.7
TCGA-25-1623-01A
0 years, female, white, stage:Stage IV, dead, 565 days
640.5
TCGA-25-1626-01A
0 years, female, white, stage:Stage IIIC, dead, 518 days
620.4
TCGA-13-2060-01A
0 years, female, white, stage:Stage IV, alive, 2369 days
619.5
TCGA-09-2054-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 637 days
612.2
TCGA-25-1323-01A
0 years, female, white, stage:Stage IIIC, dead, 395 days
602.3
TCGA-13-1492-01A
0 years, female, white, stage:Stage IIIC, dead, 3819 days
596.9
TCGA-25-2401-01A
0 years, female, white, stage:Stage IIIC, dead, 90 days
588.7
TCGA-29-1769-01A
0 years, female, white, stage:Stage IIIC, alive, 699 days
565.6
TCGA-04-1514-01A
0 years, female, white, stage:Stage IIIA, dead, 1720 days
562.8
TCGA-24-2289-01A
0 years, female, white, stage:Stage IV, dead, 2049 days
562.5
TCGA-29-2428-01A
0 years, female, white, stage:Stage IIIC, alive, 1372 days
558.4
TCGA-WR-A838-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 304 days
542.2
TCGA-61-1737-01A
0 years, female, white, stage:Stage IV, alive, 1364 days
541.6
TCGA-29-1762-01A
0 years, female, white, stage:Stage IV, dead, 2634 days
523.3
TCGA-09-1669-01A
0 years, female, white, stage:Stage IIIA, alive, 928 days
520.7
TCGA-24-1474-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 676 days
516.2
TCGA-13-1499-01A
0 years, female, white, stage:Stage IIIC, alive, 3500 days
515.2
TCGA-24-1428-01A
0 years, female, white, stage:Stage IIIC, alive, 529 days
513.6
TCGA-61-1741-01A
0 years, female, white, stage:Stage IIIB, dead, 1024 days
512.3
TCGA-13-1509-01A
0 years, female, white, stage:Stage IV, alive, 2438 days
508.3
TCGA-13-0888-01A
0 years, female, white, stage:Stage IIIC, dead, 2811 days
506.2
TCGA-13-1477-01A
0 years, female, white, stage:Stage IV, dead, 1662 days
489.7
TCGA-29-1774-01A
0 years, female, white, stage:Stage IIIC, alive, 527 days
486.5
TCGA-24-1843-01A
0 years, female, white, stage:Stage IIIC, alive, 106 days
480.1
TCGA-09-0366-01A
0 years, female, white, stage:Stage IIIC, dead, 1757 days
468.3
TCGA-24-0968-01A
0 years, female, white, stage:Stage IIIC, dead, 598 days
456.2
TCGA-13-0911-01A
0 years, female, white, stage:Stage IV, dead, 1355 days
452.5
TCGA-29-1781-01A
0 years, female, white, stage:Stage IIIC, alive, 255 days
448.8
TCGA-31-1944-01A
0 years, female, white, stage:Stage IIIC, alive, 1386 days
427.2
TCGA-61-1721-01A
0 years, female, white, stage:Stage IV, alive, 338 days
420.5
TCGA-23-1109-01A
0 years, female, white, stage:Stage IIIC, dead, 1562 days
412.5
TCGA-23-1116-01A
0 years, female, white, stage:Stage IIIC, dead, 592 days
377.0
TCGA-30-1891-01A
0 years, female, white, stage:Stage IIIC, dead, 914 days
361.9
TCGA-04-1364-01A
0 years, female, white, stage:Stage IIIC, dead, 1024 days
357.0
TCGA-57-1582-01A
0 years, female, white, stage:Stage IIIC, dead, 731 days
350.4
TCGA-04-1356-01A
0 years, female, white, stage:Stage IIC, dead, 1499 days
348.7
TCGA-29-1768-01A
0 years, female, white, stage:Stage IV, dead, 952 days
348.1
TCGA-24-2027-01A
0 years, female, white, stage:Stage IV, dead, 3337 days
336.7
TCGA-59-2363-01A
0 years, female, asian, stage:Stage IIIA, alive, 165 days
335.9
TCGA-31-1956-01A
0 years, female, white, stage:Stage IIIB, alive, 1342 days
334.6
TCGA-61-1998-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
333.3
TCGA-24-1550-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
324.8
TCGA-13-0762-01A
0 years, female, white, stage:Stage IIIC, alive, 3400 days
297.7
TCGA-25-1633-01A
0 years, female, white, stage:Stage IIIC, dead, 1891 days
282.8
TCGA-61-1907-01A
0 years, female, white, stage:Stage IIIC, alive, 952 days
261.3
TCGA-24-1427-01A
0 years, female, stage:Stage IIIC, alive, 147 days
252.3
TCGA-24-0982-01A
0 years, female, white, stage:Stage IIIC, dead, 679 days
249.2
TCGA-04-1530-01A
0 years, female, white, stage:Stage IIIC, dead, 3622 days
236.3
TCGA-25-2393-01A
0 years, female, white, stage:Stage IIIC, dead, 1157 days
220.4
TCGA-04-1338-01A
0 years, female, white, stage:Stage IIIC, alive, 1418 days
220.3
TCGA-13-1411-01A
0 years, female, white, stage:Stage IIIC, dead, 531 days
218.4
TCGA-25-1630-01A
0 years, female, white, stage:Stage IIIC, dead, 1162 days
215.8
TCGA-36-1576-01A
0 years, female, stage:Stage IIIC, alive, 915 days
213.0
TCGA-20-1686-01A
0 years, female, white, stage:Stage IIIC, alive, 89 days
211.4
TCGA-09-2048-01A
0 years, female, white, stage:Stage IIIC, dead, 138 days
197.3
TCGA-29-1691-01A
0 years, female, white, stage:Stage IIIC, dead, 1470 days
195.4
TCGA-61-2113-01A
0 years, female, white, stage:Stage IIC, dead, 676 days
179.4
TCGA-59-A5PD-01A
0 years, female, black or african american, stage:Stage IC, dead, 624 days
161.5
TCGA-13-1487-01A
0 years, female, white, stage:Stage IV, dead, 681 days
154.2
TCGA-13-1407-01A
0 years, female, white, stage:Stage IIIC, alive, 2534 days
151.9
TCGA-61-2098-01A
0 years, female, white, stage:Stage IIIC, alive, 1993 days
144.8
TCGA-24-1551-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
126.8
TCGA-25-1877-01A
0 years, female, white, stage:Stage IIIC, dead, 730 days
118.9
TCGA-30-1861-01A
0 years, female, white, stage:Stage IIIC, dead, 1058 days
111.5
TCGA-29-1761-01A
0 years, female, asian, stage:Stage IIIC, dead, 528 days
105.3
TCGA-61-2102-01A
0 years, female, white, stage:Stage IIIC, dead, 197 days
93.0
TCGA-10-0933-01A
0 years, female, white, stage:Stage IIIC, dead, 446 days
92.9
TCGA-13-1404-01A
0 years, female, white, stage:Stage IIIC, alive, 2469 days
89.4
TCGA-09-0364-01A
0 years, female, white, stage:Stage IIC, dead, 887 days
88.4
TCGA-36-1577-01A
0 years, female, asian, stage:Stage IIC, alive, 783 days
84.2
TCGA-24-1567-01A
0 years, female, white, stage:Stage IIIB, dead, 524 days
71.7
TCGA-61-2000-01A
0 years, female, white, stage:Stage IIIC, alive, 441 days
42.7
TCGA-61-2092-01A
0 years, female, white, stage:Stage IIIC, alive, 1573 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
CLU is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
1766.5
Number of samples
81
Samples
Sample
Description
TPM
DO46398
0 years, female, NA, stage:III, alive, 437 days
9951.9
DO46350
0 years, female, NA, stage:III, dead, 886 days
8634.9
DO46463
0 years, female, NA, stage:III, dead, 2451 days
6472.7
DO46591
0 years, female, NA, stage:III, dead, 195 days
6033.7
DO46326
0 years, female, NA, stage:III, dead, 701 days
5102.7
DO46404
0 years, female, NA, stage:III, dead, 690 days
4755.3
DO46360
0 years, female, NA, stage:IV, dead, 1759 days
4436.1
DO46344
0 years, female, NA, stage:III, dead, 642 days
3888.9
DO46611
0 years, female, NA, stage:III, dead, 734 days
3729.1
DO46402
0 years, female, NA, stage:III, dead, 511 days
3377.8
DO46551
0 years, female, NA, stage:III, dead, 1055 days
3274.2
DO46382
0 years, female, NA, stage:IV, dead, 311 days
3223.1
DO46384
0 years, female, NA, stage:III, dead, 614 days
3114.8
DO46392
0 years, female, NA, stage:III, dead, 628 days
3076.9
DO46378
0 years, female, NA, stage:III, alive, 843 days
2997.4
DO46528
0 years, female, NA, stage:III, alive, 6139 days
2786.0
DO46374
0 years, female, NA, stage:III, dead, 1409 days
2590.6
DO46518
0 years, female, NA, stage:III, alive, 2960 days
2466.3
DO46606
0 years, female, NA, stage:III, alive, 804 days
2415.7
DO46342
0 years, female, NA, stage:III, dead, 1398 days
2345.3
DO46366
0 years, female, NA, stage:III, dead, 2054 days
2304.7
DO46468
0 years, female, NA, stage:III, alive, 2776 days
2248.1
DO46597
0 years, female, NA, stage:III, dead, 393 days
2166.6
DO46448
0 years, female, NA, stage:III, dead, 654 days
2166.2
DO46338
0 years, female, NA, stage:III, dead, 596 days
2107.4
DO46576
0 years, female, NA, stage:III, alive, 133 days
2068.6
DO46493
0 years, female, NA, stage:IV, alive, 839 days
2028.3
DO46508
0 years, female, NA, stage:III, dead, 2101 days
1908.7
DO46400
0 years, female, NA, stage:III, dead, 719 days
1866.3
DO46327
0 years, female, NA, stage:III, dead, 184 days
1825.0
DO46340
0 years, female, NA, stage:III, dead, 616 days
1779.8
DO46386
0 years, female, NA, stage:III, dead, 1162 days
1768.9
DO46388
0 years, female, NA, stage:III, dead, 413 days
1697.0
DO46546
0 years, female, NA, stage:III, dead, 1889 days
1463.7
DO46358
0 years, female, NA, stage:III, dead, 423 days
1417.4
DO46368
0 years, female, NA, stage:III, dead, 2879 days
1413.4
DO46568
0 years, female, NA, stage:III, dead, 320 days
1392.3
DO46334
0 years, female, NA, stage:III, dead, 496 days
1376.6
DO46581
0 years, female, NA, stage:III, dead, 408 days
1240.5
DO46533
0 years, female, NA, stage:III, alive, 3667 days
1207.1
DO46332
0 years, female, NA, stage:III, dead, 689 days
1170.2
DO46325
0 years, female, NA, stage:III, dead, 477 days
1165.8
DO46566
0 years, female, NA, stage:III, dead, 673 days
1161.3
DO46356
0 years, female, NA, stage:III, dead, 911 days
1116.1
DO46408
0 years, female, NA, stage:III, dead, 489 days
1096.8
DO46352
0 years, female, NA, stage:III, dead, 677 days
1071.3
DO46538
0 years, female, NA, stage:III, dead, 1527 days
1035.1
DO46354
0 years, female, NA, stage:III, dead, 843 days
1002.4
DO46396
0 years, female, NA, stage:III, dead, 583 days
886.6
DO46513
0 years, female, NA, stage:IV, dead, 1883 days
884.2
DO46394
0 years, female, NA, stage:IV, dead, 1039 days
819.8
DO46364
0 years, female, NA, stage:III, dead, 806 days
806.2
DO46602
0 years, female, NA, stage:III, dead, 205 days
696.9
DO46370
0 years, female, NA, stage:III, dead, 1727 days
564.4
DO46329
0 years, female, NA, stage:III, dead, 1699 days
554.5
DO46523
0 years, female, NA, stage:IV, alive, 1873 days
551.3
DO46328
0 years, female, NA, stage:III, dead, 972 days
535.0
DO46376
0 years, female, NA, stage:III, dead, 1430 days
511.8
DO46561
0 years, female, NA, stage:III, dead, 195 days
506.1
DO46336
0 years, female, NA, stage:IV, dead, 664 days
502.2
DO46428
0 years, female, NA, stage:IV, alive, 2644 days
490.6
DO46438
0 years, female, NA, stage:IV, alive, 2227 days
438.8
DO46331
0 years, female, NA, stage:III, dead, 612 days
417.2
DO46346
0 years, female, NA, stage:III, dead, 1187 days
405.7
DO46362
0 years, female, NA, stage:III, dead, 1639 days
390.8
DO46560
0 years, female, NA, stage:IV, dead, 286 days
376.4
DO46333
0 years, female, NA, stage:III, dead, 359 days
343.5
DO46330
0 years, female, NA, stage:III, dead, 684 days
316.1
DO46436
0 years, female, NA, stage:III, alive, 3193 days
307.8
DO46412
0 years, female, NA, stage:III, dead, 597 days
305.2
DO46453
0 years, female, NA, stage:III, dead, 3294 days
304.4
DO46443
0 years, female, NA, stage:III, dead, 2464 days
295.5
DO46571
0 years, female, NA, stage:III, dead, 243 days
274.9
DO46390
0 years, female, NA, stage:III, dead, 374 days
274.1
DO46432
0 years, female, NA, stage:III, alive, 2218 days
268.8
DO46588
0 years, female, NA, stage:III, dead, 438 days
247.8
DO46586
0 years, female, NA, stage:III, dead, 1019 days
226.1
DO46348
0 years, female, NA, stage:IV, dead, 287 days
201.1
DO46380
0 years, female, NA, stage:III, dead, 1423 days
188.8
DO46458
0 years, female, NA, stage:IV, alive, 3787 days
169.4
DO46372
0 years, female, NA, stage:III, dead, 1326 days
91.1
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
2f901c90-617e-46da-9fac-d68369_D2
Tumor
2.6
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
2.5
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
2.1
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
1.5
340a3769-3031-41ae-bb08-a2f696_D2
Normal
1.1
a3a26070-fb84-406a-8280-d555e6_D2
Normal
1.1
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
1.1
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
0.8
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
0.8
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
0.7
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
0.7
a65d8e76-640f-4341-a561-afbb57_D2
Normal
0.7
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
0.6
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
0.6
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
0.6
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
0.6
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
0.6
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
0.6
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
0.5
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
0.5
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
0.5
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
0.5
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
0.5
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
0.5
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
0.4
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
0.4
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
0.4
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
0.3
1a10c200-3895-4648-b951-94f99f_D2
Tumor
0.3
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
0.3
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
0.3
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
0.3
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
0.2
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
0.2
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
0.2
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
0.2
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
0.2
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
0.2
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
0.2
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
0.2
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
0.2
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
0.2
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
0.1
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
0.1
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
0.1
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
0.1
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
0.1
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
0.1
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
0.1
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
0.1
161317f3-1a39-438e-af45-cd2502_D2
Tumor
0.1
285fed94-1495-448e-879b-b55de9_D2
Tumor
0.1
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
0.0
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
0.0
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
0.0
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
0.0
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
0.0
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
0.0
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
0.0
21efd60f-6a31-4b98-9477-16a905_D2
Normal
0.0
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
0.0
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
0.0
1db5574d-aca7-403c-8100-6e705f_D2
Normal
-0.1
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
-0.1
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
-0.1
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
-0.1
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
-0.1
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
-0.1
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
-0.1
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
-0.1
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
-0.1
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
-0.1
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
-0.1
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
-0.1
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
-0.2
e9d416e7-f661-400a-896e-388545_D2
Tumor
-0.2
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
-0.2
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
-0.2
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
-0.2
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
-0.2
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
-0.2
15524912-685a-47ce-a824-567848_D2
Tumor
-0.2
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
-0.3
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
-0.3
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
-0.3
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
-0.3
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
-0.4
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
-0.4
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
-0.4
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
-0.4
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
-0.4
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
-0.4
1772e913-f62e-446a-8cf3-720348_D2
Tumor
-0.5
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
-0.5
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
-0.5
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
-0.5
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
-0.5
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
-0.5
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
-0.6
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
-0.6
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
-0.6
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
-0.7
10c2d629-0287-4511-ac25-f29031_D2
Tumor
-0.7
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
-0.7
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
-0.8
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
-0.8
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
-0.8
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
-0.9
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.